Literature DB >> 17413852

Epigenetics and microRNAs.

Jody C Chuang1, Peter A Jones.   

Abstract

Epigenetics is defined as mitotically and meiotically heritable changes in gene expression that do not involve a change in the DNA sequence. Two major areas of epigenetics-DNA methylation and histone modifications-are known to have profound effects on controlling gene expression. DNA methylation is involved in normal cellular control of expression, and aberrant hypermethylation can lead to silencing of tumor-suppressor genes in carcinogenesis. Histone modifications control the accessibility of the chromatin and transcriptional activities inside a cell. MicroRNAs (miRNAs) are small RNA molecules, approximately 22 nucleotides long that can negatively control their target gene expression posttranscriptionally. There are currently more than 460 human miRNAs known, and the total number is predicted to be much larger. Recently, the expression of miRNAs has been definitively linked to cancer development, and miRNA profiles can be used to classify human cancers. miRNAs are encoded in our genome and are generally transcribed by RNA polymerase II. Despite the growing evidence for their importance in normal physiology, little is known about the regulation of miRNA expression. In this review, we will examine the relationship between miRNAs and epigenetics. We examine the effects of miRNAs on epigenetic machinery, and the control of miRNA expression by epigenetic mechanisms. Epigenetics is defined as heritable changes in gene expression that do not involve a change in DNA sequence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413852     DOI: 10.1203/pdr.0b013e3180457684

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  214 in total

1.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

Review 2.  Epigenetic mechanisms in developmental programming of adult disease.

Authors:  Man Chen; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-16       Impact factor: 7.851

3.  Computational functional genomics based analysis of pain-relevant micro-RNAs.

Authors:  Jörn Lötsch; Ellen Niederberger; Alfred Ultsch
Journal:  Hum Genet       Date:  2015-09-18       Impact factor: 4.132

Review 4.  Endothelial epigenetics in biomechanical stress: disturbed flow-mediated epigenomic plasticity in vivo and in vitro.

Authors:  Yi-Zhou Jiang; Elisabetta Manduchi; Juan M Jiménez; Peter F Davies
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

Review 5.  Metabolic programming in the pathogenesis of insulin resistance.

Authors:  Sherin U Devaskar; Manikkavasagar Thamotharan
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

Review 6.  miRNAs: effectors of environmental influences on gene expression and disease.

Authors:  Alice Hudder; Raymond F Novak
Journal:  Toxicol Sci       Date:  2008-02-16       Impact factor: 4.849

7.  Oxidative and genotoxic damages in plants in response to heavy metal stress and maintenance of genome stability.

Authors:  Subhajit Dutta; Mehali Mitra; Puja Agarwal; Kalyan Mahapatra; Sayanti De; Upasana Sett; Sujit Roy
Journal:  Plant Signal Behav       Date:  2018-08-08

8.  Highly preserved roles of Brassica MIR172 in polyploid Brassicas: ectopic expression of variants of Brassica MIR172 accelerates floral transition.

Authors:  S M Shivaraj; Aditi Jain; Anandita Singh
Journal:  Mol Genet Genomics       Date:  2018-05-11       Impact factor: 3.291

Review 9.  MicroRNAs in depression and suicide: Recent insights and future perspectives.

Authors:  Yogesh Dwivedi
Journal:  J Affect Disord       Date:  2018-07-24       Impact factor: 4.839

Review 10.  Epigenetic gene regulation in stem cells and correlation to cancer.

Authors:  Lesley A Mathews; Francesco Crea; W L Farrar
Journal:  Differentiation       Date:  2009-05-14       Impact factor: 3.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.